The impact of tissue detection on diagnostic artificial intelligence algorithms in prostate digital pathology
Clinical Snapshot
PICO Framework
| P — Population | Prostate cancer patients with whole slide images (WSIs) from 13 clinical sites, totaling 70,524 WSIs for downstream analysis |
| I — Intervention | AI-based tissue detection using UNet++ algorithm |
| C — Comparator | Classical thresholding-based tissue detection algorithm |
| O — Outcomes | Gleason grading performance, tissue detection failure rates, and clinically significant variations in AI grading |
Bottom Line
This large multi-site study demonstrates that AI-based tissue detection (UNet++) significantly reduces complete tissue detection failures compared to classical thresholding methods (0.09% vs 0.43%) in prostate cancer digital pathology. While overall Gleason grading performance was similar between methods, AI-based detection prevented missed diagnoses in nearly 100 additional cases and reduced clinically significant grading variations in 3.5% of malignant slides. The study's strength lies in its real-world validation across 13 clinical sites and multiple scanner types, enhancing generalizability. However, the lack of traditional diagnostic accuracy metrics and confidence intervals limits precision assessment. For Australian pathology services implementing digital pathology workflows, these findings suggest AI-based tissue detection may improve diagnostic reliability, particularly for slides with unusual appearances, though the clinical impact requires further validation with patient outcome data.
Key Findings
P Value: Not significant for overall Gleason grading performance
Effect Size: Reduction in fully undetected tissue samples from 118 (0.43%) to 24 (0.09%)
Primary Outcome: Gleason grading performance comparison between tissue detection methods
Nnt Or Sensitivity: AI-based detection prevented tissue detection failure in 94 additional cases (0.34% absolute reduction)
Confidence Interval: Not reported
Clinical Application
High - both methods readily implementable in existing digital pathology workflows Relevant to Australian pathology services using digital pathology platforms; aligns with RCPA digital pathology guidelines and TGA software classification requirements Patients undergoing prostate cancer diagnosis via digital pathology in routine clinical practice
Abstract
Tissue detection is a crucial first step in most digital pathology applications. By applying image segmentation algorithms, all tissue is delineated and background discarded from further analyses, improving both computational efficiency and analytical results. Details of the segmentation algorithm are rarely reported, and there is a lack of studies investigating the downstream effects of a poor segmentation algorithm. Disregarding tissue detection quality could jeopardize patient safety if diagnostically relevant parts of the specimen are excluded from analysis in clinical applications. This study aims to determine whether performance of downstream tasks is sensitive to the tissue detection method, and to compare the performance of a classical and an AI-based tissue detection approach. To this end, we trained an AI model for Gleason grading of prostate cancer in whole slide images (WSIs) using two different tissue detection algorithms: thresholding (classical) and UNet++ (AI). A total of 33,823 WSIs scanned on seven digital pathology scanners were used to train the segmentation AI model. The downstream Gleason grading algorithm was trained and tested using 70,524 WSIs from 13 clinical sites scanned on 13 different scanners. On the slides where tissue could be detected by both algorithms, no significant difference in overall Gleason grading performance was observed. There was a decrease from 118 (0.43%) to 24 (0.09%) fully undetected tissue samples when switching from thresholding-based tissue detection to AI-based, suggesting this AI model may be more reliable than the classical model for avoiding total failures on slides with unusual appearance. Moreover, tissue detection dependent clinically significant variations in AI grading were observed in 3.5% of malignant slides, highlighting the role of tissue detection for optimal clinical performance of diagnostic AI.
References
- 1.Boman, S. E., Mulliqi, N., Blilie, A., Ji, X., Szolnoky, K., Gudlaugsson, E., Janssen, E. A. M., Kjosavik, S. R., Asenjo, J., Gambacorta, M., Libretti, P., Braun, M., Kordek, R., Łowicki, R., Hotakainen, K., Väre, P., Pedersen, B. G., Sørensen, K. D., Ulhøi, B. P., Egevad, L., & Kartasalo, K. (2026). The impact of tissue detection on diagnostic artificial intelligence algorithms in prostate digital pathology. Scientific Reports. https://doi.org/10.1002/num.20129
Related Research
Cancer medicine
Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
1 Aug 2026
Head and neck pathology
A Deep Learning AI Model for Histopathological Diagnosis and Grading of Mucoepidermoid Carcinoma of Salivary Glands
22 July 2026
Journal of gastrointestinal cancer
Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature Review
9 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service